ArticleVaccine2022

Cross protective efficacy of the Non-Neurotropic live attenuated herpes simplex virus type 1 vaccine VC-2 is enhanced by intradermal vaccination and deletion of glycoprotein G.

Brent A Stanfield et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.